《中国糖尿病杂志》官方网站

20

您的位置:首页 > 中国糖尿病杂志 > 2014年 > 2期

2型糖尿病合并乙肝肝硬化患者不同糖化血红蛋白水平的血清细胞因子变化及其临床意义

来自:中国糖尿病杂志  编辑: 陈杰 徐斌 惠威 李雪梅 郭新会|点击数:|2014-03-03

  ·糖尿病临床研究·

  【摘要】 目的 观察T2DM合并乙肝肝硬化患者的不同HbA1c水平的血清细胞因子的变化。 方法 入选T2DM合并肝硬化患者65例,根据HbA1c水平分为血糖控制良好组及控制欠佳组,检测两组血清IL-2、IL4、IL-6、IL-8、IL-10、INF-γ、TNF-α水平。 结果 控制良好组血清细胞因子IL-2、TNF-α[(42.7±20.5) pg/ml、(30.5±20.2) ng/ml]低于控制欠佳组[(58.2±23.8)pg/ml、(43.5±33.7)ng/ml)],控制良好组IL-4、IL-6、IL-8水平[(3.2±1.1)、(7.1±3.7)、(58.3±50.8)pg/ml]高于控制欠佳组[(1.1±0.5)、(3.0±1.3)、(35.5±17.6)pg/ml,P<0.05]。血清IL-8、INF-γ水平两组间差异无统计学意义(P>0.05)。 结论 T2DM合并乙肝肝硬化患者良好血糖控制良好组对比血糖控制欠佳组,Th1和Th2细胞因子差异明显,其意义有待进一步探究。

  【关键词】 乙型肝炎病毒,肝硬化; 糖尿病,2型;细胞因子


Effect and its clinical significance of glycosylated hemoglobin status on serum cytokine levels of type 2 diabetes patients combined with hepatitis B virus related liver cirrhosis CHEN Jie , XU Bin, HUI Wei, et al. Department of Endocrinology and Hepatology, Youan Hospital,Capital medical university, Beijing 100069 , China

  【Abstract】 Objective To investigate the effect of serum cytokine levels in T2DM patients combined with HBV-liver cirrhosis With different glycosylated hemoglobin levels. Methods Sixty-five T2DM patients with liver cirrhosis were recruited and divided into good group ( HbA1c 6.5%,n=38) and poor group ( HbA1c>6. 5%, n=27). The serum levels of IL-2,IL4,IL-6,IL-8,IL-10,INF-γ and TNF-α were tested. Results The serum levels of IL-2 and TNF-αwere higher in good control group [(42.7±20.5) pg/ml,(30.5±20.2) ng/ml] than in poor control group [(58.2±23.8)pg/ml,(43.5±33.7)ng/ml]. The serum levels of IL4,IL-6,IL-8 were lower in good control group [(3.2±1.1),(7.1±3.7),(58.3±50.8)pg/ml]than in poor control group [(1.1±0.5),(3.0±1.3),(35.5±17.6)pg/ml,P<0.05]. Conclusion Good control blood glucose status can balance the cytokine network in hepatitis B virus-related cirrhosis patients.

  【Key words】 Hepatitis B virus, liver cirrhosis;Diabetes mellitus, type 2; Cytokine

上一篇:原发性高血压患者肾素-血管紧张素-醛固酮系统活性与血糖水平的关系 下一篇:磷酸西格列汀治疗新诊断2型糖尿病的临床观察